Over the past decade, the 'pharmacoeconomics' phenomenon has incited a stream of commentaries about the economic evaluation of drugs, conflicts of interest and ways of retaining respectability for this component of health economics profession. Private coporations now finance so many aspects of health economics, however, that the profession as a whole runs the risk of being co-opted.
Download Info
To our knowledge, this item is not available for
download. To find whether it is available, there are three
options:
1. Check below under "Related research" whether another version of this item is available online.
2. Check on the provider's web page
whether it is in fact available.
3. Perform a search for a similarly titled item that would be
available.
Length: 10 pages Date of creation: 2000 Date of revision: Handle: RePEc:fth:brichs:2000:16r
Contact details of provider: Postal: The University of British Columbia. Health Policy Research Unit. 429-2194 Health Sciences Mall. Vancouver, BC. V6T 1Z3
For technical questions regarding this item, or to correct its listing, contact: (Thomas Krichel).
Find related papers by JEL classification: I10 - Health, Education, and Welfare - - Health - - - General I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health